BRAINSTORM CELL THERAPEUTICS INC. Quotes Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG
Equities
GHDN
US10501E2019
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.497 EUR | +1.53% |
|
-7.96% | +116.09% |
| Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
| Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG| 2024-04-18 | 2024-04-19 | 2024-04-22 | 2024-04-23 | |
|---|---|---|---|---|
| Last | 0.4515 € | 0.4515 € | 0.4895 € | 0.497 € |
| Volume | 5 000 | 0 | 0 | 0 |
| Change | -7.19% | 0.00% | +8.42% | +1.53% |
| Opening | 0.50 | 0.47 | 0.49 | 0.50 |
| High | 0.50 | 0.47 | 0.49 | 0.50 |
| Low | 0.45 | 0.45 | 0.49 | 0.50 |
Performance
| 1 day | +1.53% | ||
| 1 week | -7.96% | ||
| Current month | -3.50% | ||
| 1 month | -4.42% | ||
| 3 months | +103.69% | ||
| 6 months | +214.56% | ||
| Current year | +116.09% | ||
| 1 year | -79.29% | ||
| 3 years | -81.46% | ||
| 5 years | -85.57% | ||
| 10 years | -75.46% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
36 911 436
Capitalization (USD)
36 911 436
Net sales (USD)
0
Number of employees
29
Sales / Employee (USD)
0
Free-Float
87.2 %
Free-Float capitalization (EUR)
34 445 282
Free-Float capitalization (USD)
32 185 844
Average Daily Capital Traded
0%
Highs and lows
1 week
0.45
0.50
1 month
0.450.80
Current year
0.240.80
1 year
0.112.88
3 years
0.114.45
5 years
0.1114.90
10 years
0.1114.90
Indicators
Moving average 5 days
0.48
Moving average 20 days
0.55
Moving average 50 days
0.41
Moving average 100 days
0.34
Price spread / (MMA5)
-4.02%
Price spread / (MMA20)
+11.07%
Price spread / (MMA50)
-17.30%
Price spread / (MMA100)
-32.56%
STIM
RSI 9 days
37.97
RSI 14 days
45.53
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.53% | -7.96% | +116.09% | -79.29% | 36.91M | ||
| +3.15% | +4.14% | +3.13% | +17.55% | 42.11B | ||
| +3.87% | -1.42% | +48.83% | -8.32% | 40.08B | ||
| +3.28% | +3.95% | +8.49% | -21.90% | 40B | ||
| +0.56% | +0.62% | -10.82% | +6.84% | 26.87B | ||
| +2.86% | +4.22% | +8.26% | +48.42% | 24.58B | ||
| +0.19% | -0.44% | -23.69% | -28.67% | 18.44B | ||
| +3.26% | +3.35% | +1.58% | +17.81% | 11.94B | ||
| +8.21% | +5.74% | +32.83% | +117.42% | 11.66B | ||
| +0.18% | +1.16% | +6.63% | +2.71% | 11.01B | ||
| +1.42% | -0.50% | -17.46% | -24.27% | 9.87B | ||
| +1.63% | +6.54% | -6.44% | -10.75% | 9.12B | ||
| +3.51% | -0.31% | +24.85% | -15.60% | 6.45B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| -0.45% | +0.04% | +26.45% | +57.47% | 6B | ||
| +1.87% | +0.72% | -17.30% | +17.13% | 5.99B | ||
| Average | +2.19% | -0.55% | +13.43% | +6.44% | ||
| Weighted average by Cap. | +2.61% | -0.55% | +8.96% | +7.54% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +116.09% | ||
| 2023 | -83.25% | ||
| 2022 | -60.30% | ||
| 2021 | -9.90% | ||
| 2020 | +6.67% | ||
| 2019 | +29.03% | ||
| 2018 | +12.27% | ||
| 2017 | +22.72% | ||
| 2012 | +12.50% | ||
| 2011 | +27.66% | ||
| 2010 | -45.66% | ||
| 2009 | +214.55% | ||
| 2008 | -86.90% | ||
| 2007 | +110.00% | ||
| 2006 | -50.00% | ||
| 2005 | -69.23% | ||
| 2004 | +160.00% |
- Stock Market
- Equities
- BCLI Stock
- GHDN Stock
- Quotes Brainstorm Cell Therapeutics Inc.
